In addition, several TLRs and their downstream effectors (e.g., IL-1RAP,TIRAP, MYD88, IRAK1, and TRAF6) are up-regulated in CD34+ HSPCs and malignant myeloid cells of some MDS patients [184, 185]. This evidence concerns the gene MYD88 and myelodysplastic syndrome.